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Parasitic diseases such as malaria, leishmaniasis, trypanosomia-
sis, and schistosomiasis are just one of the main causes of disease
and death in the world today (WHO, 2016). In 2016, 91 countries
reported a total of 216 million cases of malaria, which represents
an increase to 5 million cases in relation to the previous year, with
15 countries holding 80% of the global burden of malaria. The total
number of deaths worldwide reached 445.000, similar to that
reported in 2015 (WHO, 2017; Chin, 2001; Newman et al., 2016),
so there is an urgent need to discover new, safe and effective drugs
for the prophylaxis and treatment of malaria, mainly due to the
development of resistance of Plasmodium falciparum, the most
lethal Plasmodium species to chloroquine and other antimalarial
drugs. Few alternative drugs are in development and urgent mea-
sures are needed to identify new types of antimalarial agents,
many of which have originated from natural products (Olumese,
2015; Leach, 2001). Clusiaceae is one of the families of plants in
which compounds with antimalarial activity have been found, such
as xanthones and derivatives of acylphloroglucinol. Since the genus
Calophyllum is a potential source of secondary metabolites and its
species are little explored in the field of malaria, their exploration
is justified as a phytotherapeutic alternative in the treatment of
malaria (Hay et al., 2004; Chanphen et al., 1998; Pierson et al.,2010; Guillaume et al., 2009). This paper reports the isolation of
soulattrolide (1) from C. brasiliense. the preparation of eight new
derivatives (2–9) by hemi-synthesis and the bioactivity studies
thereof.
2. Materials and methods
2.1. General
NMR spectra were measured via a Varian Unity of 300 and
500 MHz for 1H; 125 and 75 MHz for 13C) spectrometers. The nat-
ure of the carbon signals (C, CH, CH2, CH3) was determined using
the APT or DEPT techniques. Assignments of the signals have been
carried out by two-dimensional heteronuclear correlations (COSY
and HMQC/HMBC). TMS was used as an internal standard. Unless
otherwise indicated, the spectra were measured in CDCl3 solution.
The X-ray data was measured via a Bruker CCD-SMART diffrac-
tometer. ESIMS were obtained from Q-TOF mass spectrometer
(Waters, Manchester, UK) with combined electrospray and APCI
ionization source with Z-spray design; the 3.5 kV capillary tension
was used in the positive direction and the cone voltage was set at
20 V. UV spectra were recorded on Genesys 2 spectrophotometer
and IR spectra were obtained by the use of KBr pellets in a Jasco
FT/IR-6200 spectrometer, covering the region 4000–600 cm1. Sil-
ica gel 60 (Merck) (70–230 mesh) were used for column chro-
matography and silica gel plates used for preparative TLC.
2.2. Plant material
The aerial parts and stems were collected in the department of
Antioquia in June 2009 by Felipe Cardona. Three types of samples
were collected from the plant material: a sample for specimen of
herbarium, samples as witnesses of the specimens collected and
samples of leaves and stems to obtain the extracts. The specimen
2 A.M. Mesa Vanegas et al. / Journal of King Saud University – Science xxx (xxxx) xxxfor herbarium was processed, deposited, taxonomically character-
ized in the herbarium Universidad de Antioquia (HUA) by Felipe
Cardona, and determined as Calophyllum brasiliense collected in
the department of Antioquia (Voucher 162,467).
2.3. Extraction and isolation
2.3.1. Isolation of soulattrolide from C. brasiliense
The air dried and powdered mixture of leaves and stems of C.
brasiliense (0,23 kg) were extracted (3 1L) using dichloromethane
(D) at room temperature. Subsequently, the extract was filtered
and concentrated in a rotary evaporator to give 47.66 g of crude
extract coded as (CBE). The extract was fractionated by vacuum liq-
uid column chromatography (VLC) over silica-gel 60 GF254 Merck
and eluted with organic solvents of ascending polarity, such as pet-
roleum ether, petroleum ether/dichloromethane gradient, ethyl
acetate and methanol. 50 fractions were collected and concen-
trated in a vacuum rotary evaporator. The fractions were unified
with similar components based on the CCD analysis, developed
with vanillin/sulfuric reagent and 12 fractions were obtained.
The major components showed a blue coloration, indicating the
presence of coumarins. Fractions 4–6 were again subjected to flash
CC using silica-gel 60 GF254 Merck with petroleum ether/ethyl
acetate gradient. A crude white colored compound was obtained
(1) (450 mg) which was purified by cold washing with ethyl
acetate.
2.4. Ester derivatives of compound (1)
Triethylamine (0.3 mmol) and the corresponding acyl chloride
(0.12 mmol) were successively added dropwise via syringe, under
nitrogen atmosphere, to a solution of compound (1) (40 mg,
0.1 mmol) and DMAP (cat) in dichloromethane (8 mL) at 0 C.
The reaction mixture was allowed to warm at room temperature
and then stirred at reflux temperature until the disappearance of
the starting material (CCD). The crude mixture was diluted in
dichloromethane (10 mL) and washed with saturated aqueous
NH4Cl (3  10 mL) and brine (3  5 mL). The organic layer was
dried over MgSO4 and concentrated under reduced pressure. Chro-
matography of the residue with a mixture of hexane/ethyl acetate
(9:1) gave a white powder (30 mg) which was crystallized from
ethyl acetate in the form of needles. Reaction of compound (1) with
4-bromobenzoyl chloride, p-toluenesulfonyl chloride, 3,5-
dinitrobenzoyl chloride, benzoyl chloride, acetyl chloride and
pentafluoro benzoyl chloride gave rise to the corresponding esters
2–7.
Compound (1) was submitted to oxidation. Thus, to a solution
of compound (1) (44 mg, 0.1 mmol) in dichloromethane (7.6 mL)
was added PCC (0 C, 15 mmol) and celite (1.2 mmol). The reaction
mixture was left stirring at room temperature for 24 h under nitro-
gen. The crude reaction was diluted with dichloromethane (10 mL)
and washed with saturated aqueous NH4Cl (3  10 mL). The
organic phase was dried over MgSO4 and concentrated under
reduced pressure to give compound (8).
On the other hand, hydrogenation of compound (1) (50 mg,
0.1 mmol) in dichloromethane in the presence of 10% Pd/C (2 mol
%), at room temperature for 24 h, filtration over celite and removal
of solvent under reduce pressure afforded compound (9).
2.5. Spectroscopic data of soulattrolide and derivatives
Soulattrolide (1): Amorphous white solid with formula
C25H24O5 (1597.6 mg), IR mmax 3431.71; 2975.62, 1714.41,
1639.2; 1587.13; 1145.51 cm1. [a]D = 33.48 (c = 0.09, CHCl3).
TOF MS ES+ [M+Na]: (MeOH) m/z obsd 427.1529 (1,9 ppm) [M
+Na]+, calculated for C25H24O5Na 427.1521. 1H-RMN-500 MHz dPlease cite this article as: A. M. Mesa Vanegas, S. Blair Trujillo, C. Peláez Jaram
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(d, 1H, J = 10.27 Hz); 5.94 (s, 1H); 5.34 (d, 1H, J = 10.23 Hz); 5.02
(d, 1H, J = 3.42 Hz); 4.28 (dq, 1H, J = 10.76, 6.36 Hz); 2.88 (bs,
1H); 1.76 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.42 (d, 3H,
J = 6.36 Hz); 1.14 (d, 3H, J = 7.34 Hz); 0.93 (s, 3H); 0.92 (s, 3H).
13C-RMN-125 MHz d (CHCl3 –d1) (ppm): 160.6; 156.3; 153.5;
153.7; 151.1; 139.9; 127.53; 127.3 (CH  2); 127.1 (CH  2);
115.9; 111.6; 106.1; 106.0; 103.0; 76.9; 73.0; 61.7; 61.3; 38.22;
26.84; 26.73; 18.80; 12.49.
Compound (2): White crystals with formula C32H27O6Br. IR
(KBr) mmax 3431, 2975, 2933, 1714, 1587, 1370, 1145, 768 cm1.
[a]D = 33.48 (c = 0.09, CHCl3). TOF MS ES+ [M+Na]+: (MeOH) m/z
obsd 609.0894 (0,8 ppm) [M+Na]+, calc for C32H27O6BrNa
609.0889. 1H NMR-500-MHz, CDCl3) d 7.93 (d, 2H, J = 7.85) 7.55
(d, 2H, J = 7.88); 7.35 (m, 3H); 7.26 (m, 2H); 6.66 (d, 1H, J = 3,43);
6.50 (d, 1H, J = 9.78 Hz); 5.85 (s, 1H); 5.34 (d, 1H, J = 9.78 Hz);
4.28 (dq, 1H, J = 12.71, 6.36 Hz); 2.88 (bs, 1H); 1.76 (ddq, 1H,
J = 10.76, 7.33, 3.42 Hz); 1.42 (d, 3H, J = 6.36 Hz); 1.14(d, 3H,
J = 6.84 Hz); 0.93 (s, 3H); 0.92 (s,3H). 13C-RMN-125 MHz (100-
MHz, CDCl3) 164.64; 159.50; 155.31; 154.11; 153.73; 151.78;
139.9; 131.58 (CH  2); 131.38 (CH  2); 129.15; 127.89; 127.54;
127.35; 127.30; 115.70; 112.536; 105.74; 103.17; 103.17;
101.92; 73.84; 64.39; 37.98; 27.07; 26.86; 18.79; 12.2.
Compound (3): C32H30SO7. 1H NMR (300-MHz, CDCl3) d 7.79 (d,
2H); 7. 34 (d, 2H); 7.37 (m, 3H); 7.24 (m, 2H); 6.68 (d, 1H,
J = 9.98 Hz); 5.96 (s, 1H); 5.36 (d, 1H, J = 9.78 Hz); 5.23 (d, 1H,
J = 3.49 Hz); 4.16 (dq, 1H, J = 10.76, 6.36 Hz); 2.22 (s, 3H); 1.96
(ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.44 (d, 3H, J = 6.36 Hz); 1.07
(d, 3H, J = 7.34 Hz); 0.95 (s, 3H); 0.94 (s, 3H).
Compound (4): C32H26N2O10 1H NMR (300-MHz, CDCl3) d 9.22
(t, 1H, J = 2.06 Hz); 9.18 (d, 1H, J = 2.07 Hz); 7.37 (m, 3H); 7.22
(m, 2H); 6.81 (d, 1H, J = 9.98 Hz); 6.58 (d, 1H, J = 3.49 Hz); 5.92
(s, 1H); 5.43 (d, 1H, J = 9.78 Hz); 4.26 (dq, 1H, J = 10.76, 6.36 Hz);
2.22 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.52 (d, 3H, J = 6.36 Hz);
1.17 (d, 3H, J = 7.34 Hz); 0.98 (s, 3H); 0.97 (s, 3H).
Compound (5): C32H28O6 1H NMR (300-MHz, CDCl3) d 8.14 (m,
2H); 7.57 (m, 1H); 7.45 (m, 2H); 7.37 (m, 3H); 7.22 (m, 2H); 6.79
(d, 1H, J = 9.98 Hz); 6.58 (d, 1H, J = 3.49 Hz); 5.92 (s, 1H); 5.43 (d,
1H, J = 9.78 Hz); 4.26 (dq, 1H, J = 10.76, 6.36 Hz); 2.22 (ddq, 1H,
J = 10.27, 6.85, 2.94 Hz);1.52 (d, 3H, J = 6.36 Hz); 1.17(d, 3H,
J = 7.34 Hz); 0.98 (s, 3H); 0.97 (s, 3H).
Compound (6): C27H26O6 1H NMR (300-MHz, CDCl3) d 7.35 (m,
3H); 7.21 (m, 2H); 6.52 (d, 1H, J = 10.27 Hz); 6,45 (br, 1H); 5.92
(s, 1H); 5.34 (d, 1H, J = 9.78 Hz); 4.28 (dq, 1H, J = 10.76, 6.36 Hz);
2,18 (s, 3H); 1.88 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.42 (d, 3H,
J = 6.36 Hz); 1.09 (d, 3H, J = 7.34 Hz); 0.93 (s, 3H); 0.82 (s, 3H).
Compound (7): C32H23F5O6 1H NMR (300-MHz, CDCl3) d 7.35
(m, 3H); 7.21 (m, 2H); 6,45 (br, 1H); 5.92 (s, 1H); 5.86 (d, 1H);
5.34 (d, 1H, J = 9.78 Hz); 4.28 (dq, 1H, J = 10.76, 6.36 Hz); 2,18 (s,
3H); 1.88 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.42 (d, 3H,
J = 6.36 Hz); 1.09 (d, 3H, J = 7.34 Hz); 0.93 (s, 3H); 0.82 (s, 3H).
Compound (8): C25H22O5 1H NMR (300-MHz, CDCl3) d 7.37 (m,
3H); 7.24 (m, 2H); 6.63 (d, 1H, J = 9.98 Hz); 6.03 (s, 1H); 5.41 (d,
1H, J = 9.78 Hz); 4.32 (dq, 1H, J = 10.76, 6.36 Hz); 2.22 (s, 3H);
2.56 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.54 (d, 3H, J = 6.36 Hz);
1.16 (d, 3H, J = 7.34 Hz); 0.95 (s, 3H); 0.94 (s, 3H).
Compound (9): C25H26O5 1H NMR (300-MHz, CDCl3) d 7.41 (m,
3H); 7.32 (m, 2H); 5.92 (s, 1H); 4.28 (dq, 1H, J = 10.76, 6.36 Hz);
2,18 (s, 3H); 1.88 (ddq, 1H, J = 10.27, 6.85, 2.94 Hz); 1.42 (d, 3H,
J = 6.36 Hz); 1.09 (d, 3H, J = 7.34 Hz); 0.93 (s, 3H); 0.82 (s, 3H).
2.6. Test of biological activity
2.6.1. Plasmodium falciparum culture
For the assays the culture-adapted P. falciparum strain NF54
(chloroquine sensitive) was used. Maintenance in continuousillo et al., , Journal of King Saud University –
A.M. Mesa Vanegas et al. / Journal of King Saud University – Science xxx (xxxx) xxx 3culture was according to the methodology previously described by
Trager and Jensen (1976); Parasites were cultivated in suspension
of 5% human A + erythrocytes in RPMI-1640 culture medium
(Sigma R6504) dissolved in sterile water with 25 mM HEPES,
5.0% NaHCO3, 10% fresh human A + serum (inactivated at 56 C
for 30 min); incubated in an atmosphere of 5% O2, 5% CO2 and
90% N2. Daily change was performed and fresh red blood cells were
added twice a week.
2.6.2. Determination of antiplasmodial activity
Antiplasmodial activity was measured by the SYBR Green I
method and was adapted according to the methodology described
by Smilkstein et al. (2004). Assays were performed on Falcon 96-
well flat bottom plates. A suspension of parasitized red blood cells
with a hematocrit of 2.5% and a parasitaemia of 1% was prepared.
Wells with compounds to test and with chloroquine as positive
control were incubated at 37 C for 48 h in an atmosphere of 5%
CO2, 5% O2 and 90% of N2. Subsequently, the contents of each well
were transferred to Greiner Pro one dishes and the parasites were
labeled with a solution of SYBR Green I 2X in lysis buffer. The
plates were incubated at room temperature for one hour in the
dark and the relative fluorescence units (RFU) were read on a spec-
trofluorometer at an excitation wavelength of 485 nm and emis-
sion length of 538 nm. Treatments from each crude extract were
prepared to a stock solution of 10 mg/mL in pure DMSO and soni-
cated to facilitate dissolution. From this solution, 50 lL were taken
and adjusted to 1000 lL with complete RPMI-1640 medium,
obtaining a final concentration of 0.5 mg/mL. The concentration
of DMSO in the first dilution, which was 1%, has been shown to
be non-toxic to the parasite. Seven concentrations of each extract
were evaluated in a range between 100 and 1.56 lg/mL. Each con-
centration was evaluated in duplicate on the plate and three inde-
pendent assays were performed. The CQ control was evaluated in a
range between 150 and 4.7 nM and the control of Peruvian Quina
extract (MeOH:H2O; 70:30) was evaluated in the range of 0.01–
10 lg/mL.
2.6.3. Determination of the inhibitory concentration
Data from three assays were analyzed to find the inhibitory
concentration IC50 in lg/mL. Inhibitory concentrations (IC50 ± SD)
were calculated for each compound from a non-linear logistic
regression model. A sigmoid concentration-response curve with
slope of Hill (variable slope) was assumed. The data were analyzed
and plotted using GraphPad Prism 4 for Macintosh version 4.0b
which outputs the adjustment value (r) (GraphPad Software, San
Diego, California, USA). To classify the antiplasmodial activity of
an extract, the Malaria Group of the University of Antioquia
established a consensus for the extracts evaluated: highly active
<5 lg/mL, promising 6–15 lg/mL, moderate activity 16–30 lg/mL,
low activity 31–50 lg/mL and non-active >50 lg/mL (Malebo
et al., 2009; Muñoz et al., 2000). To classify the antiplasmodial
activity of a compound, the Malaria Group estimated that a com-
pound is promising if the IC50 is 10 lM.
2.6.4. Cytotoxicity testing and calculation of the selectivity index (SI)
The method of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) according to Mosmann (1983) was used to
evaluate the cytotoxic activity of the extracts (Mosmann, 1983)
which reveals cellular damage at the mitochondrial level. U-937
cells were human histiocytic lymphoma promonocytes, which
were maintained in continuous cultures in the Malaria Group Lab-
oratory. These cells were cultured at 37 C and 5% CO2 in RPMI
medium supplemented with 10% inactivated Fetal Bovine Serum
(FBS). The media changes were performed every 48 h or according
to pH changes of the medium, with centrifugation for 10 min at
1000 rpm, replaced with fresh medium. In Neubauer’s chamber,Please cite this article as: A. M. Mesa Vanegas, S. Blair Trujillo, C. Peláez Jaram
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200,000 cells/mL in RPMI 1640 medium with 10% FBS. They were
incubated at 37 C with 5% CO2 for 72 h in the presence of each
of the seven concentrations of each extract and/or compound eval-
uated in a range between 100 and 1.56 lg/mL, each concentration
was evaluated in duplicate in the dish and three independent
assays were performed. Subsequently, mitochondrial dehydroge-
nase activity was measured by adding 20 lL/well of MTT to a con-
centration of 5 mg/mL and incubating for 3 h at 37 C and 5% CO2
(Moore et al., 1967). To dissolve the formed crystals, 100 lL/well
of a 50% solution of isopropanol and 10% SDS were added and
the absorbance read at 595 nm in an ELISA reader (Bio-Rad). Data
from three independent assays were analyzed using the GraphPad
Prism 5 program to find the toxic concentration in lg/mL (CC50)
using a non-linear logistic regression model (Reed et al., 2002).
For the assay, the HepG2 cells were counted in a Neubauer cham-
ber and seeded in a 96-well flat bottom plate 2  105 cells/well in
100 lL of RPMI-1640 medium with 10% fetal bovine serum. Subse-
quently, the cells were incubated for 30 h at 37 C in a 5% CO2 envi-
ronment, to allow the formation of the monolayer and then add
100 lL of each of the concentrations (100–1.54 lg/mL) of the
extracts and/or compounds or 100 lL of the medium in which
the extracts and/or compounds were dissolved. Four wells were
left, to which culture medium was added to evaluate the behavior
of the cells under normal conditions (negative control). Each con-
centration of extracts and/or compounds and controls were evalu-
ated in quadruplicate in 2 assays. Plates were incubated for 48 h at
37 C. Then, 30 lL of MTT (Sigma Aldrich) was added at a concen-
tration of 2 mg/mL and incubated again for 5 h. After incubation,
130 lL of 96% DMSO were added and the dishes were incubated
for 20 min at room temperature and gently mixed to allow the
MTT crystals to dissolve. The production of Formazan crystals is
measured at 550 nm in an ELISA reader (Bio-Rad). The toxic effect
was determined by comparing the absorbance obtained in the con-
trol with that of the treatments and thus determining whether or
not there was a toxic effect. Data were analyzed with the GraphPad
Prism 5 program to find CC50 (cytotoxic concentration inhibiting
50% growth). To classify the cytotoxicity of the extract, the Malaria
Group of the University of Antioquia established a consensus for
the samples evaluated: highly toxic <10 lg/mL, cytotoxic 10–
40 lg/mL, moderately cytotoxic 41–100 lg/mL and not cytotoxic
>100 lg/mL. In addition, the selectivity index (SI) was calculated,
which indicates selectivity towards the parasite and corresponds
to the relationship between cytotoxic CC50 activity and antiplas-
modial activity IC50. For the HepG2 cell line, SI values above 5 were
considered as promising extracts (Kaou et al., 2008).
2.6.5. Inhibition of the crystallization of b-hematin
Evaluation of the inhibition of b-hematin crystallization of com-
pounds 1 and 2 was done by the method of Paparini et al. (2000)
with some modifications (Paparini et al., 2000). A total of 100 lL
of a 1.562 mM solution of hemin chloride dissolved in 0.2 M NaOH
was distributed in 96-well microplates (0.4 lmol/well) with multi-
channel pipette together with 50 lL of different concentrations of
compounds in a range: 5.0–0.078 mg/mL dissolved in dimethylsul-
foxide (DMSO) and the CQ control was evaluated in a range of 3.0–
0.094 mg/mL. It was added in duplicate and two replicates of the
assay were performed. In the control wells, 50 lL of DMSO for
wells without treatment and chloroquine control were added as
reference. The formation of b-hematin was initiated by the addi-
tion of 50 lL of acetic acid 2.175 M to a final pH of 2.8 and 50 lL
of sodium acetate buffer (C2H3NaO23H2O) 0.75 M. The plate was
incubated at 37 C for 24 h and then centrifuged at 4500g for 1 h.
The soluble fraction of the material was discarded. The rest was
suspended with 200 lL of DMSO:H2O ratio 1:1 to remove the unre-
acted hematin. The dishes were again centrifuged at 4500g forillo et al., , Journal of King Saud University –
Fig. 1. X-ray characterization of soulattrolide (1).
Fig. 2. ORTEP II drawing of the crystal structure for derivative (2). Major ellipses of
atoms other than hydrogen are graphed with a 50% probability level. Hydrogen
atoms have been drawn as spheres of arbitrary size.
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itate was dissolved in 0.2 M NaOH for spectroscopic quantification.
An aliquot of 50 lL from each well was transferred to a new dish
with 150 lL of 0.2 M NaOH. A sample blank at the same concentra-
tions dissolved in 150 lL of 0.2 M NaOH was used. Before the
readings, the formation of b-hematin was determined spectropho-
tometrically in a Spectronic 20 UV–Vis in the range of 250–800 nm.
The amount of b-hematin inhibited by each of the extracts was
determined by measuring the absorbance at 595 nm using an
ELISA reader (BioRad) and the % inhibition of b-hematin was calcu-
lated according to Eq. (1). Data from two assays, were analyzed
with the GraphPad Prism 5 program to find the concentration of
extract required to inhibit 50% of the formation of b-hematin in
mg/mL (IC50) by means of a non-linear logistic regression model.
%Inhibition ¼ 1 ½ðAbs sample
 Abs Sample blankÞ=ðAbs ControlÞ  100 ð1ÞPlease cite this article as: A. M. Mesa Vanegas, S. Blair Trujillo, C. Peláez Jaram
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spectrometry ESI-MS
A Quattro LC (QhQ quadrupole-hexapolar-quadrupole) with an
orthogonal mass spectrometer Z-spray-electrospray interface
(Micromass, Manchester, United Kingdom) was used. The sample
solutions (approximately 1  105 M) in acetonitrile: aqueous
0.5 M NH4OH (1:1 v/v) was introduced through a fused silica cap-
illary to the ESI source through the pump of syringe at a flow rate
of 10 lL/min. The drying gas as well as the nebulization gas was
nitrogen at a flow rate of 300 and 90 L/h, respectively. The temper-
ature of the source block was set at 80 C and the interface at
120 C. For each ion of interest, the parameters of the instrument
were optimized for the maximum ion abundance. The capillary
voltage was set at 3.5 kV in positive scan mode and the cone volt-
age was adjusted (typically 20–40 Uc V) to control the extent of
fragmentation in the source region. The extractor cone and the
radio frequency lens tension were maintained at 3 V and 0.2,
respectively. The chemical composition of each peak obtained in
the full scan mode was assigned by comparing the experimental
and theoretical isotope patterns using the program MássLynx 4.1.
3. Results and discussion
The dichloromethane extract of the air dried C. brasiliense was
fractionated using vacuum liquid chromatography (VLC) and
purified by various chromatographic techniques. The IC50 value
of the crude extract (IC50 = 7.63 ± 1.84 mg/mL) and the CC50
(35.09 ± 0.12 mg/mL) showed moderate activity and some selec-
tivity in the parasite P. falciparum, indicating that the crude
extract has potential as an antiplasmodial agent. One compound
(1) was isolated. This component called soulattrolide was isolated
and structural elucidation was achieved through spectroscopic
analysis and verified by direct comparison of the spectral data
with values from the literature. This compound has been
reported in the genus Calophyllum (Noldin et al., 2006). Com-
pound 1 was obtained as a white amorphous solid. The absolute
stereochemistry of the soulattrolide was confirmed by obtaining
a crystalline derivative for the first time. The absolute configura-
tion was assigned based on the X-ray test through the Analysis of
the crystalline derivative with 4-bromobenzoyl chloride
C32H27O6Br, also 1H NMR-NOE experiments were performed to
determine a relative configuration by comparison of the coupling
constants with other related compounds. The crystallographic
data for C32H27O6Br, were Mr = 587.44, type of orthorhombic
crystal system, spatial group P212121, a = 6.2620 (7) Å,
b = 13.8299 (16) Å, c = 31.901 (4) Å, Vcelda = 2762.7 (6) Å3, Z = 4,illo et al., , Journal of King Saud University –
Fig. 3. Synthetic derivates of soulattrolide (1).
Table 1
In vitro antiplasmodial and cytotoxicity assays of derivates of soulattrolide (1).
Code Compound Formula IC 50 (mg/mL) X ± SD* CC50(mg/mL) X ± SD SI**
P. falciparum NF-54*** HepG2 Cells
1 C25H24O5 55.45 ± 13.89 >100 1.80
2 C32H27BrO6 8.06 ± 0.96 4.71 ± 0.56 0.58
3 C32H30SO7 8.71 ± 1.00 10.68 ± 0.74 1.23
4 C32H26N2O10 19.06 ± 1.55 19,16 ± 3,01 1.00
5 C32H28O6 9.66 ± 2.53 21.84 ± 9.83 2.26
6 C27H26O6 14.21 ± 4.95 9.16 ± 4.16 0.64
7 C32H23F5O6 4.39 ± 0.83 12.61 ± 2.04 2.87
8 C25H22O5 5.13 ± 0.11 5.79 ± 1.25 1.13
9 C25H26O5 13.89 ± 3.73 15.12 ± 0.34 1.09
* The mean ± S.D.
** SI = Selectivity index CC50/IC50, SI > 2 confirm efficacy and safety.
*** Control Chloroquine IC50 = 0.008 ± 2,78 lg/mL. The definition of the antiplasmodial activity used was: IC50 < 5 lg/mL – strong activity; 6–15 lg/mL – moderate activity;
16–30 lg/mL – mild activity and IC50 > 30 lg/mL – inactive.
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Fig. 4. Analysis by mass spectrometry of the interaction of soulattrolide (1) and compound (2) with FP. Sample solutions [heme], [heme + (1)], [Heme + (2)] (approximately
1  10–5 M) in acetonitrile: 0.5 M aqueous NH4OH (1:1 v/v) (A) [heme]] (B) [heme + (1)] (C) [heme + (2)], followed by the positive ion recording ESI-MS, as shown.
Uncertainties in masses of ±0.3 Da.
6 A.M. Mesa Vanegas et al. / Journal of King Saud University – Science xxx (xxxx) xxxdcalc = 1.412 g cm3, l = 1.532 mm1, (Cu, Ka, k = 0.71073 Å),
T = 516 K. The intensity data were 2h < 30,570, 0 < h < 8,
0 < k < 19, 0 < l < 45 and their Friedel values were copied by
means of variable-speed scans x-2h. The data were corrected
for Lorentz and polarization factors, by absorption, and by decay
of isotropic intensity. The structure was solved by direct and
refined methods with the parameters of anisotropic displacement
of atoms other than hydrogen (Fig. 1).Please cite this article as: A. M. Mesa Vanegas, S. Blair Trujillo, C. Peláez Jaram
Science, https://doi.org/10.1016/j.jksus.2019.03.005The positions of the hydrogen atoms were determined from dif-
ferences of Fourier maps, but remained fixed at the positions geo-
metrically calculated in the last refinement of the isotropic factors
of assigned temperature 1.3 (Beq) of the attached atom. The com-
plete matrix was calculated with convergent least squares (in F)
refinement (max D/r = 1208.0), conventional crystallographic
reflections R = 0.0527 (4936) and R2w = 0.1401 (8186) for 8186
observations [I > 3r (I)]. 460 variables and the adjustment wereillo et al., , Journal of King Saud University –
A.M. Mesa Vanegas et al. / Journal of King Saud University – Science xxx (xxxx) xxx 71,008. A final difference of the Fourier map was monotonous; Max-
imum residual densities were close to the bromine atom (0.699
and 0.845 Å3). This assignment of the crystalline derivative con-
figuration (C19 (S); C20 (S); C21 (S) was confirmed by enantiopole
refinement and corroborated by examination of the Friedel pairs
most affected by the anomalous scattering effects (Fig. 1) In this
sense, the absolute configuration of the natural compound soulat-
trolide is (C19 (S); C20 (R); C21 (S).) The neutral factor of atomic
dispersion and the values of the anomalous dispersion terms were
taken from the international society of X-ray crystallography
(Fig. 2). This is the first time that this compound C32H27O6Br has
been reported in the literature.
Nine acid derivatives of compound (1) were obtained for first
time (Fig. 3), and were subjected to antiplasmodial and cytotoxic-
ity assays. Biological activity of 1 was 55.45 ± 13.89 or 137.08 lM,
and of the crystalline derivative of soulattrolide (2), which is
reported for the first time,was 8.06 ± 0.96 or 13.73 lM. All remain-
ing compounds (3–9) showed promising activity against the P. fal-
ciparum strain NF-54 (Table 1). A significant increase in the
antiplasmodial activity was observed with the ester (2), which
showed a reduction of the IC50 by an factor of almost 10. Fig. 4
experimentally supports the strong interaction between com-
pound 2 and b-hematin. Molecular modeling optimized and tested
the strong interaction between soulattrolide (1) and derivate (2)
with b-hematin.
4. Conclusion
The good pharmacological activities of dichloromethane extract
of C. brasiliense and isolated compounds and derivates, which were
characterized and confirmed by obtaining a crystalline derivative,
showed the importance of this study. New structural analogues
were proposed with capability of inhibition of b-hematin in order
to achieve a global understanding of the activity of the compounds
tested and to select the best antiplasmodial compound for further
studies in murine models.
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